Personalized Tumor Response Assessment in the Era of Molecular Medicine: Cancer-Specific and Therapy-Specific Response Criteria to Complement Pitfalls of RECIST
出版年份 2012 全文链接
标题
Personalized Tumor Response Assessment in the Era of Molecular Medicine: Cancer-Specific and Therapy-Specific Response Criteria to Complement Pitfalls of RECIST
作者
关键词
-
出版物
AMERICAN JOURNAL OF ROENTGENOLOGY
Volume 198, Issue 4, Pages 737-745
出版商
American Roentgen Ray Society
发表日期
2012-03-27
DOI
10.2214/ajr.11.7483
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Progression-free survival (PFS) from a phase I study of crizotinib (PF-02341066) in patients with ALK-positive non-small cell lung cancer (NSCLC).
- (2017) D. R. Camidge et al. JOURNAL OF CLINICAL ONCOLOGY
- Changes in Tumor Density in Patients with Advanced Hepatocellular Carcinoma Treated with Sunitinib
- (2011) S. Faivre et al. CLINICAL CANCER RESEARCH
- Targeted Therapies for the Treatment of Metastatic Renal Cell Carcinoma: Clinical Evidence
- (2011) T. E. Hutson ONCOLOGIST
- Tumor Biology and Prognostic Factors in Renal Cell Carcinoma
- (2011) D. S. Finley et al. ONCOLOGIST
- Morphology, Attenuation, Size, and Structure (MASS) Criteria: Assessing Response and Predicting Clinical Outcome in Metastatic Renal Cell Carcinoma on Antiangiogenic Targeted Therapy
- (2010) Andrew Dennis Smith et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) P. G. Casali et al. ANNALS OF ONCOLOGY
- Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
- (2010) S. J. O'Day et al. ANNALS OF ONCOLOGY
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Efficacy and safety of motesanib, an oral inhibitor of VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant gastrointestinal stromal tumors
- (2010) Robert S. Benjamin et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Clinical Implications of the Cancer Genome
- (2010) Laura E. MacConaill et al. JOURNAL OF CLINICAL ONCOLOGY
- New CT response criteria in non-small cell lung cancer: Proposal and application in EGFR tyrosine kinase inhibitor therapy
- (2010) Ho Yun Lee et al. LUNG CANCER
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessing Tumor Response and Detecting Recurrence in Metastatic Renal Cell Carcinoma on Targeted Therapy: Importance of Size and Attenuation on Contrast-Enhanced CT
- (2009) Andrew Dennis Smith et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma
- (2009) J. Weber et al. CLINICAL CANCER RESEARCH
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- Current systemic therapy for metastatic melanoma
- (2009) Sanjiv S Agarwala Expert Review of Anticancer Therapy
- Personalized Cancer Therapy With Selective Kinase Inhibitors: An Emerging Paradigm in Medical Oncology
- (2009) Ultan McDermott et al. JOURNAL OF CLINICAL ONCOLOGY
- Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
- (2009) Jedd D Wolchok et al. LANCET ONCOLOGY
- High-Grade Soft-Tissue Sarcomas: Tumor Response Assessment—Pilot Study to Assess the Correlation between Radiologic and Pathologic Response by Using RECIST and Choi Criteria
- (2009) Silvia Stacchiotti et al. RADIOLOGY
- Role of sunitinib and sorafenib in the treatment of metastatic renal cell carcinoma
- (2008) J. J. Hiles et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Current management of metastatic melanoma
- (2008) V. A. Trinh AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033
- (2008) Charles D. Blanke et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor Cavitation: Impact on Objective Response Evaluation in Trials of Angiogenesis Inhibitors in Non–Small-Cell Lung Cancer
- (2008) Simon J. Crabb et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor Cavitation During Therapy with Antiangiogenesis Agents in Patients with Lung Cancer
- (2008) Edith M. Marom et al. Journal of Thoracic Oncology
- Response Evaluation of Gastrointestinal Stromal Tumors
- (2008) H. Choi ONCOLOGIST
- Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
- (2008) F. S. Hodi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Radiologic Measurements of Tumor Response to Treatment: Practical Approaches and Limitations
- (2008) Chikako Suzuki et al. RADIOGRAPHICS
- CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS
- (2008) F Stephen Hodi et al. Nature clinical practice. Oncology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started